Vol. 284, Issue 6, C1584-C1592, June 2003
Chloro(2,2':6',2"-terpyridine) platinum inhibition of the
renal Na+,K+-ATPase
Nancy T.
Ruddock,
Krista L.
Arnett,
Betty Jo
Wilson, and
Mark A.
Milanick
Department of Physiology, School of Medicine, and Dalton
Cardiovascular Research Center, University of Missouri, Columbia,
Missouri 65211
Chloro(2,2':6',2"-terpyridine)
platinum, a bulky, hydrophilic reagent, inhibited the renal sodium pump
with a single exponential time course. K+ increased the
rate constant of the reaction by about twofold; the K+
concentration dependence was monotonic, with a half-maximal effect observed at 1 mM, consistent with K+ acting at a transport
site. Na+, Mg2+, eosin, and vanadate did not
significantly alter the rate of reaction. The results of proteolysis
and mass spectrometer analysis were consistent with terpyridine
platinum labeling of Cys452, Cys456, or Cys457. Because phenylarsine
oxide reacts with vicinal cysteines and did not prevent terpyridine
platinum modification, terpyridine platinum most likely modifies
Cys452. This modification prevents ADP binding; interestingly, the
analogous residue in sarco(endo)plasmic reticulum
Ca2+-ATPase (SERCA) is on the exterior of the
nucleotide-binding pocket. Thus it appears that the terpyridine
platinum residue is more accessible in the presence of K+
than in its absence and that terpyridine platinum modification prevents
nucleotide binding.
sodium pump; chemical modification; active transport